Access to a second PBS-listed abobotulinumtoxin A (Dysport) is now available for the treatment of moderate-severe spasticity of the upper limb in children with cerebral palsy from two years of age. The PBS listing is supported by evidence from a phase III study recently published in Developmental Medicine and Child Neurology. The study comprised 210 ...
New PBS listing for Dysport in cerebral palsy
By Mardi Chapman
2 Dec 2020